Optimal Phlebotomy Interval to Change Hematocrit Levels in Patients with Polycythemia / 대한수혈학회지
Korean Journal of Blood Transfusion
;
: 220-228, 2016.
Artículo
en Inglés
| WPRIM
| ID: wpr-201803
ABSTRACT
BACKGROUND:
Phlebotomy is used to maintain hematocrit levels 4 weeks.RESULTS:
No patients with secondary polycythemia and 25.8% of the patients with PV had thrombotic events pre-phlebotomy. Post-phlebotomy, none of the patients experienced a thrombotic event. The average decrease in hematocrit level was significantly different between the three groups, being 1.98±1.90% (4 weeks).CONCLUSION:
To prevent thrombotic events, phlebotomy is a safe and effective treatment to reduce hematocrit levels in patients with polycythemia, regardless of medication. For the maximum effect, a <2-week phlebotomy interval to reduce and <4-week phlebotomy interval to maintain hematocrit levels could be effective.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Arritmias Cardíacas
/
Policitemia
/
Policitemia Vera
/
Trombosis
/
Flebotomía
/
Hematócrito
/
Hidroxiurea
/
Hipertensión
Límite:
Humanos
Idioma:
Inglés
Revista:
Korean Journal of Blood Transfusion
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS